PEG-IFN-α-2a therapy in patients with myelofibrosis

被引：47
|
作者：
Ianotto, Jean-Christophe [1 ]
Kiladjian, Jean-Jacques [2 ]
Demory, Jean-Louis [3 ]
Roy, Lydia [4 ]
Boyer, Francoise [5 ]
Rey, Jerome [6 ]
Dupriez, Brigitte [7 ]
Berthou, Christian [1 ]
Abgrall, Jean-Francois [8 ]
机构：
[1] Hop Morvan, CHU, Inst Canc Hematol, Serv Hematol Clin, Brest, France
[2] AP HP, Serv Hematol Clin, Bobigny, France
[3] Hop St Vincent, Dept Hematol, Lille, France
[4] CHU La Miletrie, Dept Oncohematol & Therapie Cellulaire, Poitiers, France
[5] CHU Angers, Serv Malad Sang, Angers, France
[6] Inst J Paoli I Calmettes, Dept Oncohematol, F-13009 Marseille, France
[7] CH, Serv Hematol Clin, Lens, France
[8] CHU Brest, Hop Cavale Blanche, Hematol Lab, F-29285 Brest, France
来源：
BRITISH JOURNAL OF HAEMATOLOGY | 2009年 / 146卷 / 02期
关键词：
myelofibrosis; treatment; pegylated-interferon; response criteria; European Myelofibrosis Network; MYELOID METAPLASIA; POLYCYTHEMIA-VERA; INTERFERON; CRITERIA;
D O I：
10.1111/j.1365-2141.2009.07745.x
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：223 / 225
页数：3
相关论文
共 50 条
  • [21] The relationship between the clearance of HBsAg and the remodeling of B cell subsets in CHB patients treated with Peg-IFN-α
    Wu, Ze-Qian
    Tan, Lei
    Gan, Wei-Qiang
    Mo, Zhi-Shuo
    Chen, Da-Biao
    Wang, Pei-Pei
    Zhao, Qi-Yi
    Xie, Dong-Ying
    Gao, Zhi-Liang
    ANNALS OF TRANSLATIONAL MEDICINE, 2021, 9 (05)
  • [22] PEG-IFN-α-2b therapy in BCR-ABL-negative myeloproliferative disorders -: Final result of a phase 2 study
    Jabbour, Elias
    Kantarjian, Hagop
    Cortes, Jorge
    Thomas, Deborah
    Garcia-Manero, Guillermo
    Ferrajoli, Alessandra
    Faderl, Stefan
    Richie, Mary Ann
    Beran, Miloslav
    Giles, Francis
    Verstovsek, Srdan
    CANCER, 2007, 110 (09) : 2012 - 2018
  • [23] Autoimmune thrombocytopenia induced by PEG-IFN-α plus ribavirin in hepatitis C
    Demirturk, Nese
    Cevik, Figen
    Demirdal, Tuna
    Aykin, Nevil
    Aslan, Vahap
    PLATELETS, 2006, 17 (05) : 340 - 343
  • [24] THE EFFECT OF TREATMENT GROUP, HCV GENOTYPE, AND IL28B GENOTYPE ON EARLY HCV VIRAL KINETICS IN A PHASE 2A STUDY OF PEG-INTERFERON LAMBDA (PEG-IFN-λ) IN HEPATITIS C PATIENTS
    Freeman, Jeremy A.
    Gray, Todd E.
    Fontana, David
    Lopez-Talavera, Juan Carlos
    Miller, Dennis M.
    Hillson, Jan L.
    HEPATOLOGY, 2010, 52 (04) : 721A - 721A
  • [25] Detection and characterization of antibodies to PEG-IFN-α2b using surface plasmon resonance
    Takacs, MA
    Jacobs, SJ
    Bordens, RM
    Swanson, SJ
    JOURNAL OF INTERFERON AND CYTOKINE RESEARCH, 1999, 19 (07): : 781 - 789
  • [26] Autoimmune thrombocytopenia induced by PEG-IFN-α2b plus ribavirin in hepatitis C
    Sagir, A
    Wettstein, M
    Heintges, T
    Häussinger, D
    DIGESTIVE DISEASES AND SCIENCES, 2002, 47 (03) : 562 - 563
  • [27] Efficacy of PEG-IFN-alfa 2a(Pegasys) vs Pegasys and RBV for HIV/HCV coinfected patients that are nonresponders to previous IFN therapy.
    Rodriguez-Torres, M
    Rodriguez-Orengo, J
    HEPATOLOGY, 2003, 38 (04) : 325A - 325A
  • [28] PEG-IFN alfa 2a induced immidiate cytokine
    Antonov, K.
    Jelev, D.
    Kolchakov, V.
    Krastev, Z.
    JOURNAL OF HEPATOLOGY, 2008, 48 : S223 - S224
  • [29] Addition of nucleoside analogues to peg-IFNα-2a enhances virological response in chronic hepatitis B patients without early response to peg-IFNα-2a: a randomized controlled trial
    Yan Xu
    Xu Wang
    Zhenhua Liu
    Changyu Zhou
    Wenqian Qi
    Jian Jiao
    Fan Yu
    Honghua Guo
    Ping Zhao
    Jiangbin Wang
    BMC Gastroenterology, 17
  • [30] Addition of nucleoside analogues to peg-IFNα-2a enhances virological response in chronic hepatitis B patients without early response to peg-IFNα-2a: a randomized controlled trial
    Xu, Yan
    Wang, Xu
    Liu, Zhenhua
    Zhou, Changyu
    Qi, Wenqian
    Jiao, Jian
    Yu, Fan
    Guo, Honghua
    Zhao, Ping
    Wang, Jiangbin
    BMC GASTROENTEROLOGY, 2017, 17
12345